Pfizerology: the lessons of deconstruction
This article was originally published in Scrip
Executive Summary
Bubbling just under the surface of any current US conversation about Big Pharma – and I suspect some conversations around the world – is a recent exposé on management dysfunction at the highest levels of Pfizer.